Singapore- Vermillion, a bio-analytical solutions company focused on gynecologic disease, announced that it intends to o...
Singapore- A new peer-reviewed, published study shows that natural French maritime pine bark extract Pycnogenol is effec...
Singapore - Abbott announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo st...
Singapore - GSK and Orchard Therapeutics signs a strategic agreement, under which GSK will transfer its p...
Singapore - Under its De Novo (no predicate product) review pathway, the FDA approves the first medical device in t...
Singapore - Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced it ha...
M&A deal making continues with Alexion Pharmaceuticals swapping up Wilson Therapeutics AB for USD 855 millio...
Singapore - Zealand Pharma and Roche’s Diabetes Care unit will partner on Phase 3 clinical trials assess...
Singapore - Inovio Pharmaceuticals is up 6% premarket on average volume on the heels of its announcement&...
Singapore - Perrigo Company plc announced that it has received final approval from the U.S. Food & Drug Administrati...
US-based Ionis Pharmaceuticals, the leader in antisense therapeutics, recently announced that it has licensed IONI...
Clinical Stage Company Immunomedics has announced the appointment of Robert Iannone as Head of Research & Developmen...
Singapore – Switxerland- based Novartis AG has agreed to acquire Bannockburn, Illinois-based company AveXis for US...
Singapore - Amarantus Bioscience Holdings has reacquired the rights to three neurology- focused diagnostic tests from Av...
Singapore - The Maple Grove-based company, Inspire Medical Systems, which sells its proprietary Inspire therapy for slee...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has announced an international distribution and co-...
Singapore- As drug-resistant pathogens continue to spread throughout the U.S., hundreds of hospitals throughout the coun...
Singapore- Roche finalizes its $1.9B acquisition of Flatiron Health, a developer of oncology-focused electroni...
